CDRE
Cadre Holdings, Inc.
CDRE has slightly lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CDRE overall, supported by stronger valuation and stronger fundamentals.
CDRE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Under pressure |
CDRE's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CDRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $33.08 | — |
| Cheap | 32x | $29.19 | -12% |
| Fair | 35x | $31.42 | -5% |
| Current | 37x | $33.08 | — |
| Expensive | 39x | $35.21 | +6.4% |
Historical ranges are pointers, not guarantees.
CDRE's PE is in its fair range at 37x. If earnings grow as analysts expect, today's price would be 23x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CDRE in the historical PE scenario, which offers more potential upside but is not a forecast.
CDRE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CDRE, with profitability improving. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CDRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.43 | +59% |
| Q3 2026 | $0.90 | -20% |
| Q2 2026 | $0.80 | -15% |
| Q1 2026 | $0.84 | -12% |
| Q4 2025 | $1.02 | +13% |
| Q3 2025 | $1.12 | +35% |
| Q2 2025 | $0.94 | -8.7% |
| Q1 2025 | $0.95 | -5.9% |
| Q4 2024 | $0.90 | -12% |
CDRE's earnings per share have fallen from their peak: $0.90 over the past year, against $1.21 in early 2021.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CDRE on earnings, with more consistent year-over-year improvement.
CDRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $202.9M | +30% |
| Q2 2026 | $207.1M | +32% |
| Q1 2026 | $155.4M | +19% |
| Q4 2025 | $167.2M | -5% |
| Q3 2025 | $155.9M | +42% |
| Q2 2025 | $157.1M | +8.9% |
| Q1 2025 | $130.1M | -5.6% |
| Q4 2024 | $176M | +41% |
CDRE's revenue is growing: $203M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +2 points |
| Q2 2026 | 11% | +1.5 points |
| Q1 2026 | 4.8% | -5.6 points |
| Q4 2025 | 12% | -4.5 points |
| Q3 2025 | 12% | +7 points |
| Q2 2025 | 9.3% | -4.5 points |
| Q1 2025 | 10% | +1.7 points |
| Q4 2024 | 17% | +6.5 points |
CDRE's operating margin was 14% last quarter, up 2 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CDRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CDRE on profitability, with a higher operating margin.
CDRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $19.9M | -8.2% |
| Q2 2026 | $18.7M | +1505% |
| Q1 2026 | $19.8M | +23% |
| Q4 2025 | $18M | -20% |
| Q3 2025 | $21.6M | +$27.9M |
| Q2 2025 | $1.2M | -87% |
| Q1 2025 | $16.1M | +1925% |
| Q4 2024 | $22.4M | -8.4% |
CDRE generated $76M in free cash flow over the past year, up 25% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CDRE on cash flow, with more consistent year-over-year improvement.
CDRE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +77.4K shares |
| 1 year | +6.1% | +2.5M shares |
| 3 years | +15% | +5.5M shares |
| 5 years | +58% | +16M shares |
| Available history | +26% | +8.8M shares |
CDRE has 43M diluted shares, up 6.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has the edge over CDRE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CDRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 2.1x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 2.2x | Moderate |
| Q1 2025 | 1.0x | Healthy |
| Q4 2024 | 1.2x | Healthy |
CDRE's net debt is about 3.0 years of its operating earnings (EBITDA), up from 1.7 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CDRE on leverage, with a lower net debt burden relative to earnings.
CDRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 65.2 | Neutral |
CDRE's weekly RSI is 58 (neutral) and its Stochastic is 65 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CDRE PE vs Industrials Sector
| Metric | CDRE | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 24x | 53% above |
| PE % | 65 | 66 | 1 pt below |
CDRE has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CDRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.5 | 16% above |
| 20 week MA | $29.7 | 11% above |
| 50 week MA | $33.6 | 1.4% below |
| 100 week MA | $34.0 | 2.7% below |
| 200 week MA | $31.9 | 3.8% above |
CDRE has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CDRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.3 | $21.3 | +39% |
| 2022 | $21.3 | $20.1 | -5.4% |
| 2023 | $20.1 | $32.9 | +64% |
| 2024 | $32.9 | $32.1 | -2.6% |
| 2025 | $32.1 | $41.9 | +31% |
| 2026 YTD | $41.9 | $33.1 | -21% |
CDRE has finished higher in three of the last five years. It's down 21% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CDRE on returns for 2026, with the stronger performance.